assertion (references)

Nanopublication	Part	Subject	Predicate	Object	Published By	Published On
http://purl.org/np/RA4XU6f7MOg0xzZ0Z9htwczrA1R1MxyfYYxS5VoKpUxrg RA4XU6f7MO	links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance	assertion	http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo	https://orcid.org/0000-0002-3668-2627 Elif Ozkan	Elif Ozkan	2022-10-13T13:40:02.752Z
http://purl.org/np/RA4XU6f7MOg0xzZ0Z9htwczrA1R1MxyfYYxS5VoKpUxrg RA4XU6f7MO	links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance	assertion	http://www.w3.org/ns/prov#generatedAtTime generatedAtTime	2022-10-13T13:40:02.752577	Elif Ozkan	2022-10-13T13:40:02.752Z
http://purl.org/np/RA4XU6f7MOg0xzZ0Z9htwczrA1R1MxyfYYxS5VoKpUxrg RA4XU6f7MO	links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance	assertion	http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom	OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. The spray is available for adults and adolescents 12 years and 12 years old. The product is available in the US and Europe for $1,800 ($1,300) in the U.S. and Europe. The manufacturer of the product has been approved by FDA and European Patent Patent Company.	Elif Ozkan	2022-10-13T13:40:02.752Z